Diagnostic Accuracy of Cardiochek® Pa Point-of-care Testing (Poct) Analyser With a 3-in-1 Lipid Panel for Epidemiological Surveys

Author:

Lourdes Tania Gayle Robert1,Lin Chong Zhuo1,Saminathan Thamil Arasu1,Hamid Hamizatul Akmal Abd1,Rifin Halizah Mat1,Wan Kim Sui1,Majid Nur Liana Ab1,Yogaratnam Kishwen Kanna1,Riyadzi Mohd Ruhaizie1,Ismail Hasimah1,Yusoff Muhammad Fadhli Mohd1

Affiliation:

1. National Institutes of Health, Ministry of Health

Abstract

Abstract Background Point-of-care testing (POCT) is commonly used in epidemiological surveys due to its various advantages, such as portability and immediate test results. The CardioChek® PA analyser 3-in-1 lipid panel measures total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol. This study tested the reliability and diagnostic accuracy of the CardioChek® PA analyser using a 3-in-1 lipid panel. Methods A cross-sectional study design with quota sampling was used. A total of 203 respondents aged 18 years and above from a research centre in the Ministry of Health, Malaysia, were recruited. Venous blood was sent to the laboratory, while a POCT analyser was used for capillary blood measurements. Intraclass coefficient correlation (ICC) analysis was employed to determine the agreement between capillary and venous blood parameters. The diagnostic performance of the evaluated tests was evaluated using STATA version 12. Results The agreement between capillary and laboratory venous blood was moderate (0.64–0.67) for TC and HDL, good (0.75) for LDL and excellent (0.91) for TG). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were as follows: TC, 57.1%, 94.3%, 92.3% and 64.8%; TG, 76.0%, 100%, 100%, and 96.6%; HDL, 96.2%, 83.2%, 47.2% and 99.3%; and LDL, 81.0%, 100%, 100% and 68.3%, respectively. Conclusions The CardioChek® PA analyser showed acceptable diagnostic accuracy for screening high-risk individuals more often in places where laboratories are inaccessible. It could also be used in clinical settings where patients would benefit from swift treatment decisions.

Publisher

Research Square Platform LLC

Reference31 articles.

1. World Health Organization (WHO). Noncommunicable diseases [Internet]. 2021 [cited 2022 Feb 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.

2. Wengrofsky P, Lee JMA. Dyslipidemia and Its Role in the Pathogenesis of Atherosclerotic Cardiovascular Disease: Implications for Evaluation and Targets for Treatment of Dyslipidemia Based on Recent Guidelines. In: SI M, editor. IntechOpen; 2019. Available from: https://www.intechopen.com/chapters/66725 10.5772/intechopen.85772.

3. Global Trends in the Epidemiology and Management of Dyslipidemia;Liu T;J Clin Med,2022

4. Institute for Public Health. National Health and Morbidity Survey (NHMS). 2019: NCDs - Non-Communicable Diseases: Risk Factors and other Health Problems [Internet]. Vol. 1, Institute for Public Health, National Institutes of Health (NIH), Ministry of Health Malaysia. 2019. Available from: https://iku.moh.gov.my/images/IKU/Document/REPORT/NHMS2019/Report_NHMS2019-NCD_v2.pdf.

5. Hypercholesterolemia Prevalence, Awareness, Treatment and Control among Adults in Malaysia: The 2015 National Health and Morbidity Survey, Malaysia;Mat Rifin H;Glob J Health Sci,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3